Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

354 recalls, newest first

Class II · Moderate risk

Fludrocortisone Acetate Tablets

Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification limits.

Ongoing Impurity / degradation Teva Pharmaceuticals USA, Inc NDC 0555-0997-02 D-0601-2024
Class III · Low risk

Diflorasone Diacetate Ointment

Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.

Ongoing Impurity / degradation Rising Pharma Holding, Inc. NDC 64980-124-60 D-0599-2024
Class III · Low risk

SinuFrin Decongestant

Sub-potent Drug

Ongoing Other Neilmed Pharmaceuticals Inc NDC 13709-325-01 D-0569-2024
Class II · Moderate risk

Dianeal Low Calcium

Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.

Ongoing Sterility / contamination Baxter Healthcare Corporation D-0587-2024
Class III · Low risk

Eszopiclone Tablets

Failed Impurities/Degradation Specifications: Related Substances

Ongoing Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-629-30 D-0581-2024

Recalls by year